CD44 and breast cancer: In our studies both the breast cancer cell lines MDA-M-231 and MCF-7 and the primary culture of patient breast cancer cells demonstrated enhanced expression of phosphorylated ATM in the CD44+/CD24−or low subpopulation after radiation.